Startups
Overview
Total raised
$12.4M
Funding Rounds 1
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 5
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jun 29, 2010 | BIND Biosciences Secures $12.4M in Series C-1 Financing | BIND Biosciences, Inc., a Cambridge, MA-based biopharmaceutical company developing targeted polymeric nanoparticle-based therapeutics that deliver high drug concentrations to diseased cells and tissues, has secured $12.4m in a Series C-1 fi... |
| Jan 14, 2010 | BIND Biosciences closes $11 M Series C financing round | BIND Biosciences, Inc., a Cambridge, MA-based biopharmaceutical company developing targeted therapeutics capable of differential delivery and controlled drug exposure to diseased tissue, secured an $11m Series C financing. The financing was... |
| Nov 9, 2007 | Bind Biosciences, My IPO Prediction, and Brain Overload at MassOpps | Share Share on Facebook Share on Twitter LinkedIn Email Reprints I just got back from MassOpps—a life sciences PowerPointapalooza put on by the Massachusetts Biotechnology Council—and boy my brain is tired. In conference rooms at the Logan ... |
| Oct 11, 2007 | Life sciences briefing: Thursday, Oct. 11, 2007 | Featured companies: Ablynx, Bind Biosciences, Maas Biolab, Oriel Therapeutics, ThromboVision, Xcellerex (UPDATED: See below.) Contract biomanufacturer Xcellerex pulls in $31M — Marlborough, Mass.-based Xcellerex, a startup that provides con... |
Reviews 0
FAQ about BIND Biosciences, Inc.
How much funding has BIND Biosciences, Inc. raised?
BIND Biosciences, Inc. has raised $12.4M in total across 1 funding round.
What has the press written about BIND Biosciences, Inc.?
Parsers VC has collected 5 articles mentioning BIND Biosciences, Inc., among them “BIND Biosciences Secures $12.4M in Series C-1 Financing” (Jun 29, 2010) and “BIND Biosciences closes $11 M Series C financing round” (Jan 14, 2010).
Is BIND Biosciences, Inc. still active?
BIND Biosciences, Inc. is probably closed: its latest activity on Parsers VC dates from Jan 20, 2012.